A switching mechanism in doxorubicin bioactivation can be exploited to control doxorubicin toxicity.
Although doxorubicin toxicity in cancer cells is multifactorial, the enzymatic bioactivation of the drug can significantly contribute to its cytotoxicity. Previous research has identified most of the components that comprise the doxorubicin bioactivation network; however, adaptation of the network t...
Saved in:
| Main Authors: | Nnenna A Finn, Harry W Findley, Melissa L Kemp |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2011-09-01
|
| Series: | PLoS Computational Biology |
| Online Access: | https://journals.plos.org/ploscompbiol/article/file?id=10.1371/journal.pcbi.1002151&type=printable |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Reducing toxicity and enhancing efficacy of doxorubicin by liposomal doxorubicin and aprepitant in breast cancer
by: Atefeh Ghahremanloo, et al.
Published: (2025-03-01) -
Temporal analysis of doxorubicin-induced cardiac toxicity and hypertrophy
by: Yu-Te Lin, et al.
Published: (2025-07-01) -
Effects of Dulaglutide in Doxorubicin Induced Renal Toxicity in Rats
by: Hama Said HJ, et al.
Published: (2025-07-01) -
Can Dexrazoxane and Carvedilol prevent Doxorubicin-induced nephrotoxicity?
by: Szponar Jaroslaw, et al.
Published: (2024-12-01) -
Static magnetic field promotes the doxorubicin toxicity effects on osteosarcoma cells
by: Fatemeh Rajabi, et al.
Published: (2025-04-01)